Thursday, February 28, 2013

Ed Silverman's Pharmalot blog-What’s Not To Like? Facebook And The FDA


Last month, the FDA tagged a dietary supplement maker for a laundry list of infractions, but one item tucked away in a December 11 warning letter stands out. The agency complained to Amarc Enterprises that one of its products was ‘liked’ last year on its Facebook page. This was cited as one example of numerous testimonials that could be construed as claims that cause the Poly MVA supplement to be considered a drug. - See more at: http://www.pharmalot.com/2013/02/whats-not-to-like-facebook-and-the-fda/#sthash.ewA1JpWz.dpuf

No comments: